In this trial, 342 men with sildenafil-failure ED were given either intranasal PT-141 (10 mg dose) or placebo on demand over ~48 weeks.The outcomes demonstrated a clear benefit of bremelanotide: About 33.5% of men on bremelanotide achieved a positive clinical response (improved erections sufficient for intercourse) compared to only 8.5% on placebo
Heavier individuals with more adipose tissue often benefit from doses at the higher end of the standard range (450-500mcg)
May 05, 2025 How we source info
Feeling drained, sluggish, and lacking energy
In scientific and technical literature, Tesamorelin and Ipamorelin may appear in broader research contexts involving metabolic regulation, body composition modeling, or physiological adaptation mechanisms
TB-500 Research Foundation Landmark research published in Nature by Bock-Marquette et al